Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • SciSure Reviews & Ratings
    311 Ratings
    Company Website
  • QBench Reviews & Ratings
    153 Ratings
    Company Website
  • Lockbox LIMS Reviews & Ratings
    72 Ratings
    Company Website
  • Qualio Reviews & Ratings
    919 Ratings
    Company Website
  • Digital WarRoom Reviews & Ratings
    55 Ratings
    Company Website
  • FrameworkLTC Reviews & Ratings
    48 Ratings
    Company Website
  • JDisc Discovery Reviews & Ratings
    30 Ratings
    Company Website
  • IONOS Cloud GPU Servers Reviews & Ratings
    45,340 Ratings
    Company Website
  • Criminal IP ASM Reviews & Ratings
    21 Ratings
    Company Website
  • AthenaHQ Reviews & Ratings
    50 Ratings
    Company Website

What is BenevolentAI?

BenevolentAI is a groundbreaking platform that harnesses the power of artificial intelligence and advanced scientific methodologies to improve the drug discovery process, particularly for challenging diseases, by swiftly analyzing and interpreting vast amounts of biomedical data to generate practical insights more quickly than traditional methods. Through its distinctive Benevolent Platform, the company adeptly combines both structured and unstructured biomedical data—including literature, genomic information, clinical records, and multi-omics—into a comprehensive knowledge graph. This sophisticated structure enables researchers to explore biological systems, develop testable hypotheses, discover new drug targets, and design potential drug candidates with greater assurance and lower chances of failure, thereby revolutionizing the field of medicine development. By pioneering such innovative strategies, BenevolentAI not only enhances the efficiency of pharmaceutical research but also significantly impacts the future of healthcare and treatment options. As a result, BenevolentAI is positioned as a leader in ushering in a transformative phase within the pharmaceutical sector.

What is Atomwise?

Our cutting-edge AI platform is transforming the drug discovery landscape, allowing us to create high-quality medications more rapidly than ever before. Backed by a wide array of discovery assets, both independently owned and co-developed with partners, and supported by prestigious investors, we are making considerable advancements in the sector. Atomwise has developed a machine-learning discovery engine that harnesses the power of convolutional neural networks in conjunction with vast chemical libraries to pinpoint new small-molecule drugs. The true potential of AI in revolutionizing drug discovery is rooted in the dedication and expertise of our team. We are committed to developing state-of-the-art AI tools that enhance the discovery of small molecules, targeting some of the most challenging and seemingly impossible objectives while optimizing the overall drug development process. By increasing computational efficiency, we can digitally screen trillions of compounds, significantly improving the likelihood of successful outcomes. Our models have achieved exceptional accuracy, effectively reducing the occurrence of false positives and setting the stage for groundbreaking medical innovations. As we continue to refine our technology, our ultimate goal is to equip researchers with the necessary tools to inspire innovation and deliver impactful results in the realm of drug discovery. This commitment to advancing the field is at the core of our mission.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

API Availability

Pricing Information

Pricing not provided

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Standard Support
Web-Based Support

Customer Service / Support

Web-Based Support

Training Options

Documentation Hub
Online Training

Training Options

Documentation Hub
Webinars
On-Site Training

Company Facts

Organization Name

BenevolentAI

Date Founded

2013

Company Location

Luxembourg

Company Website

www.benevolent.com

Company Facts

Organization Name

Atomwise

Date Founded

2012

Company Location

United States

Company Website

www.atomwise.com

Categories and Features

AI Science

Not specified

Drug Discovery

Not specified

Life Sciences

Not specified

Categories and Features

Drug Discovery

Not specified

Healthcare AI

Not specified

Popular Alternatives

Popular Alternatives

StarDrop Reviews & Ratings

StarDrop

Optibrium
AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA
Scitara DLX Reviews & Ratings

Scitara DLX

Scitara